node_name	node_type	
DB00563	drug	
SLC22A6	drug_target	
TYMS	drug_target	
FOLR1	drug_target	
SLC46A1	drug_target	
SLC22A8	drug_target	
ABCC4	drug_target	
ABCG2	drug_target	
SLC19A1	drug_target	
SLC16A1	drug_target	
ALB	drug_target	
AOX1	drug_target	
SLC22A11	drug_target	
ABCC10	drug_target	
PGD	drug_target	
ABCC2	drug_target	
ABCC3	drug_target	
ABCC11	drug_target	
MTHFR	drug_target	
SLCO3A1	drug_target	
SLCO1A2	drug_target	
SLCO1B3	drug_target	
GGH	drug_target	
DHFR	drug_target	
ABCB1	drug_target	
ABCC1	drug_target	
SLCO1B1	drug_target	
SLCO1C1	drug_target	
ATIC	drug_target	
FPGS	drug_target	
Palmar hyperkeratosis	phenotype	
Adverse drug events and drug allergies	phenotype	
Plantar hyperkeratosis	phenotype	
Hippocampal sclerosis	phenotype	
Folic Acid Deficiency	phenotype	
Kidney Diseases	phenotype	
Epidermolysis bullosa simplex, Cockayne-Touraine type	phenotype	
Abnormality of the plantar skin of foot	phenotype	
 Cerebrovascular disease, occlusive (3)	phenotype	
Nephrotic Syndrome, Minimal Change	phenotype	
Palmoplantar keratoderma, nonepidermolytic, focal	phenotype	
Hereditary hyperhomocysteinemia	phenotype	
Myofibrillar myopathy, BAG3-related	phenotype	
Abnormality of metabolism/homeostasis	phenotype	
Cholecystolithiasis	phenotype	
Aneurysm, Ruptured	phenotype	
Drug-Induced Liver Injury	phenotype	
Recurrent E. coli infections	phenotype	
Hyperlipidemia, combined, 1	phenotype	
Congenital disorder of glycosylation	phenotype	
Intrahepatic cholestasis	phenotype	
Abnormality of circulating protein level	phenotype	
Skin Diseases, Genetic	phenotype	
Cholelithiasis	phenotype	
Plaque, Atherosclerotic	phenotype	
Neoplasm of the liver	phenotype	
Gastrointestinal Diseases	phenotype	
Membranous nephropathy, susceptibility to	phenotype	
Von Willebrand disease, recessive form	phenotype	
Hyperkeratosis	phenotype	
Myelosuppression	phenotype	
Acute myocardial ischemia	phenotype	
Cerebral Amyloid Angiopathy	phenotype	
Abnormality of blood and blood-forming tissues	phenotype	
Mesangiocapillary glomerulonephritis, type II	phenotype	
Drug Eruptions	phenotype	
Bleeding with minor or no trauma	phenotype	
Abnormal blistering of the skin	phenotype	
Tetraplegia	phenotype	
Neurotoxicity Syndromes	phenotype	
Vascular Diseases	phenotype	
Brain Ischemia	phenotype	
Spots on skin	phenotype	
Hyperbilirubinemia	phenotype	
Abnormality of the skin	phenotype	
Hyperlipoproteinemia	phenotype	
Old myocardial infarction	phenotype	
Hypertriglyceridemia result	phenotype	
Bleeding disorder, platelet-type, 21	phenotype	
Familial hypercholesterolemia	phenotype	
Leukopenia	phenotype	
Anemia, Sickle Cell	phenotype	
Sickle Cell Trait	phenotype	
Choroidal Neovascularization	phenotype	
Chronic Kidney Insufficiency	phenotype	
Hemorrhagic disorder due to intrinsic circulating anticoagulants	phenotype	
Insulin resistance syndrome	phenotype	
Epidermal thickening	phenotype	
Carotid Atherosclerosis	phenotype	
Abnormality of the level of lipoprotein cholesterol	phenotype	
Nail dystrophy	phenotype	
Lipoatrophy	phenotype	
Onset	phenotype	
Abnormality of skin morphology	phenotype	
Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	phenotype	
Autosomal dominant non-syndromic sensorineural deafness type DFNA	phenotype	
Familial type 3 hyperlipoproteinemia	phenotype	
Geographic Atrophy	phenotype	
Other disorders of the nervous system	phenotype	
Intracranial Aneurysm	phenotype	
Impaired vibratory sensation	phenotype	
body mass	phenotype	
Drug Resistant Epilepsy	phenotype	
Hyperlipidemia, familial combined	phenotype	
Kidney Failure, Chronic	phenotype	
Homocysteinemia due to MTHFR deficiency	phenotype	
Primary biliary cirrhosis	phenotype	
Corneal Diseases	phenotype	
SPHEROCYTOSIS, TYPE 1 (disorder)	phenotype	
Cardiovascular Diseases	phenotype	
Renal Insufficiency, Chronic	phenotype	
Oral leukoplakia	phenotype	
Stage 5 chronic kidney disease	phenotype	
Abnormality of the immune system	phenotype	
Factor V Leiden mutation	phenotype	
Dermal atrophy	phenotype	
Down Syndrome	phenotype	
Acute kidney injury	phenotype	
Abnormal albumin level	phenotype	
Coronary heart disease 7	phenotype	
Thickened skin	phenotype	
Peripheral neuropathy, myopathy, hoarseness, and hearing loss	phenotype	
Drug Allergy	phenotype	
Dermatosis NOS	phenotype	
Hereditary spherocytosis	phenotype	
Hypercholesterolemia, autosomal dominant, type B	phenotype	
Abnormality of the abdominal organs	phenotype	
Abnormality of immune system physiology	phenotype	
Chromosome 11p deletion syndrome	phenotype	
Azorean disease	phenotype	
Hyperhidrosis	phenotype	
Pregnancy loss	phenotype	
Abnormality of humoral immunity	phenotype	
Elevated hepatic transaminases	phenotype	
Hereditary factor VIII deficiency disease	phenotype	
Abnormality of the liver	phenotype	
Brain Hemorrhage, Traumatic	phenotype	
Mesothelioma, malignant	phenotype	
Age-related macular degeneration 2	phenotype	
Restenosis	phenotype	
Visceromegaly	phenotype	
Acute Coronary Syndrome	phenotype	
Myelomeningocele	phenotype	
Abnormality of circulating enzyme level	phenotype	
Abnormality of abdomen morphology	phenotype	
Homocystinuria due to CBS deficiency	phenotype	
Elevated serum creatine phosphokinase	phenotype	
Bone necrosis	phenotype	
HELLP Syndrome	phenotype	
Hemolytic uremic syndrome	phenotype	
Recurrent skin infections	phenotype	
Liver Diseases	phenotype	
Papilloma	phenotype	
Diabetic Angiopathies	phenotype	
Stroke	phenotype	
Cholestasis, benign recurrent intrahepatic 1	phenotype	
cardiac event	phenotype	
Femur Head Necrosis	phenotype	
Pyruvate carboxylase deficiency	phenotype	
Hyperthyroidism	phenotype	
Mild cognitive impairment	phenotype	
Exanthema	phenotype	
Nephrotic syndrome, type 5, with or without ocular abnormalities	phenotype	
